ASHPOfficial

Pharmacogenomics is a unique area of practice that student pharmacists may not know very much about. This podcast episode provides an overview of pharmacogenomic residency opportunities so that students may consider this avenue for post-graduate training.   

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In Part Two of this podcast series (straight from the 2020 Midyear Clinical Meeting), Dr. Igneri describes the clinical manifestations of COVID-19 associated coagulopathy, shares best practices on interpreting the available literature and given a patient scenario, design a treatment plan to manage COVID-19 associated coaguopathy.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Are you a student pharmacist seeking to learn more about ambulatory care practice and residency training? With the vast array of training options, including residency programs with ambulatory care tracks, it may be difficult to identify the best fit for you. This podcast episode reviews various types of ambulatory care programs as well as questions students should ask when researching post-graduate training. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Accuracy in diagnosis is critical for treating infectious diseases. In honor of U.S. Antibiotic Awareness Week (November 18-24, 2021), this Therapeutic Thursday podcast episode features an expert from the CDC and a physician and epidemiologist from the University of Maryland School of Medicine in Baltimore, Maryland. Our guests discuss diagnostic and antibiotic stewardship and how disease overestimation during diagnosis impacts antimicrobial prescribing behaviors. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Learn from experts in the field on contemporary diagnosis and management of C diff infection. Topics include new diagnostic strategies and best treatment plans for our patients.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Embedded Clinical Pharmacists at Penn Presbyterian Medical Center’s clinics serve as members of an interdisciplinary team that confirm clinical appropriateness of specialty medications, ensure medication access, provide medication counseling and the specialty pharmacy complies with Utilization Review Accreditation Commission (URAC) regulations to maintain accreditation status. With the advent of COVID-19, these serves shifted to a telemedicine approach. In her 2020 Midyear Clinical Meeting presentation, Dr. Diane Kim shares her institution’s successes with transition and how her team demonstrated value to the specialty services.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

This session from the 2020 Midyear Clinical Meeting, planned in cooperation with the ASHP Section of Clinical Specialists and Scientists, features a review of recent updates to the ADHD treatment guidelines and compares and contrasts newer formulations of ADHD medications.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

Brought to you by the Section of Ambulatory Care Practitioners, this podcast episode features excerpts from the 2020 Midyear Clinical Meeting Design disease focused progressive pharmacy care models for a rural population and features virtual or telehealth models to reach rural-based populations, examples of standardized approaches for key rural practice areas, and identifies barriers faced in rural care settings.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

In Part One of this podcast, straight from the 2020 Midyear Clinical Meeting, Dr. Igneri describes the clinical manifestations of COVID-19 associated acute respiratory distress syndrome and shares best practices on interpreting the available literature and given a patient scenario, design a treatment plan to manage COVID-19 associated ARDS. 

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.

The opioid needs for a palliative care patient do not follow the same rules as pain management. In this highlight from the 2020 Midyear Clinical Meeting, content matter experts from the Section of Ambulatory Care Practitioners compare and contrast the difference in therapy goals between opioid tapering in the palliative care population and the general population and compare possible opioid tapering regimens for both a general population patient and a palliative care patient.

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.